Drug reformulation
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
856
NCT02831088
Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC)
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2016
Completion: Dec 30, 2018
NCT03651557
Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients
Start: Nov 29, 2018
Completion: May 31, 2021
NCT05041010
Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz
Phase: Phase 3
Start: Dec 25, 2021
Completion: Jan 31, 2025
Loading map...